Abstract:Cells that undergo terminal cell cycle arrest (senescence) are a hot topic in aging research due in part to their senescence associated secretory phenotype (SASP), composed of chemokines and inflammatory cytokines, which negatively affect the local microenvironment. In the mouse, muscle stem cells, satellite cells, undergo senescence with advancing age, which has been proposed to contribute to sarcopenia. Whereas loss of satellite cells in mouse muscle neither accelerates nor exacerbates sarcopenia, satellite cell SASP has been proposed to contribute to muscle wasting with age. There is currently no evidence that satellite cells in aged human muscle undergo senescence. p16 and γH2AX (markers of cellular senescence and DNA‐damage, respectively) are used to identify senescent cells in vitro and in tissues in vivo, but have not been examined in human muscle as a function of age. The purpose of our study was to examine the effectiveness of these markers in human skeletal muscle to quantify the abundance of senescent satellite cells during aging. Muscle biopsies were obtained from the vastus lateralis in young (18–25 years) and old (65–86 years) men and women, and immunohistrochemistry (IHC), combined with DAPI staining, were used to quantify p16 and/or γH2AX positive nuclei that expressed Pax7, a satellite cell marker. An antibody against dystrophin was also used to specifically localize myofiber nuclei. Surprisingly, >95% of all nuclei expressed p16 in both young and old muscle. However, labeled nuclei were preferentially localized within the muscle fiber, suggesting that in muscle, p16 is a marker of post‐mitotic, differentiated myonuclei. p16 positive satellite cell and non‐myogenic nuclei are currently being counted, as well as co‐expression with γH2AX, to attempt to identify and quantify all senescent cells in human muscle from both young and old donors. We conclude that p16 is not an ideal marker of cellular senescence in human skeletal muscle. Transient p16 expression in satellite cells may be an indicator of quiescence, while p16 expression in post‐mitotic myonuclei may be keeping them from re‐entering the cell cycle. Additional studies are needed to identify better markers of cellular senescence to determine if SASP potentially contributes to human muscle aging.

p16 and γH2AX as Markers of Cellular Senescence in Young and Old Human Skeletal Muscle